Aspire Biopharma Holdings, Inc. (ASBP) - Latest Market Data

Price & Market Data

Price: $5.39

Daily Change: -$0.20 / 3.71%

Daily Range: $5.30 - $5.86

Market Cap: $7,007,215

Daily Volume: 71,153

Performance Metrics

1 Week: -5.24%

1 Month: -14.99%

3 Months: -88.22%

6 Months: -95.49%

1 Year: -98.06%

YTD: -96.75%

About Aspire Biopharma Holdings, Inc. (ASBP)

Comprehensive financial data on Aspire Biopharma Holdings, Inc. (ASBP). Trading at 5.39, it has a daily change of -$0.20 / 3.71%. Market cap: 7,007,215. Review its performance from the last week to the last year.

Details

Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, such as melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.

Selected stocks

Yiren Digital Ltd. (YRD)

Connect Biopharma Holdings Limited (CNTB)

Xcel Brands, Inc (XELB)

The Generation Essentials Group (TGE)

Gelteq Limited (GELS)